Core Scientific (CORZ) Net Cash Flow (2021 - 2026)

Core Scientific (CORZ) has 6 years of Net Cash Flow data on file, last reported at $834.6 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 703.67% year-over-year to $834.6 million; the trailing twelve-month figure through Mar 2026 stood at $447.3 million (down 23.47% YoY), and the FY2025 full-year result was -$525.6 million, down 168.5% from the prior year.
• Net Cash Flow rose to $834.6 million in Q1 2026, from -$142.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $834.6 million in Q1 2026 to a low of -$142.1 million in Q4 2025.
• A 5-year average of $59.7 million and a median of $5.8 million in 2023 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow soared 10014.08% in 2024 and sank 583.59% in 2025, its largest moves.
• Tracing CORZ's Net Cash Flow over 5 years: stood at $14.6 million in 2022, then tumbled by 60.5% to $5.8 million in 2023, then soared by 10014.08% to $583.2 million in 2024, then tumbled by 124.36% to -$142.1 million in 2025, then soared by 687.48% to $834.6 million in 2026.
• Business Quant data shows CORZ's Net Cash Flow at $834.6 million in Q1 2026, -$142.1 million in Q4 2025, and -$127.9 million in Q3 2025.